Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay L. Goldstein

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Journal of Clinical Gastroenterology|January 14, 2021
Bile Acid Sequestrant Therapy in Microscopic ColitisMichael J Northcutt, Nicole M Gentile, Jay L Goldstein, et al.
The American Journal of Gastroenterology|April 22, 2005
Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritisLinda Rabeneck, Jay L Goldstein, An Vu, et al.
The Journal of Rheumatology|January 5, 2005
Cyclooxygenase-2 specific inhibitors and upper gastrointestinal tolerability in patients with osteoarthritis receiving concomitant low dose aspirin: pooled analysis of 2 trialsJay L Goldstein, Alfonso E Bello, William Spalding, et al.
Digestive Diseases and Sciences|August 7, 2007
Endoscopic ulcer rates in healthy subjects associated with use of aspirin (81 mg q.d.) alone or coadministered with celecoxib or naproxen: a randomized, 1-week trialJay L Goldstein, James Aisenberg, Salam F Zakko, et al.
The American Journal of Gastroenterology|January 26, 2002
Reliability, validity, and responsiveness of severity of dyspepsia assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapyLinda Rabeneck, Kimberly Wristers, Jay L Goldstein, et al.
Digestive Diseases and Sciences|August 22, 2009
GERD-related health care utilization, therapy, and reasons for transfer of GERD patients between primary care providers and gastroenterologists in a US managed care settingRachel Halpern, Smita Kothari, Mahesh Fuldeore, et al.
Annals of the Rheumatic Diseases|August 5, 2006
The rate of NSAID-induced endoscopic ulcers increases linearly but not exponentially with age: a pooled analysis of 12 randomised trialsMaarten Boers, Marco J D Tangelder, Hein van Ingen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 8, 2006
Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complicationsJay L Goldstein, Kimberly B Howard, Surrey M Walton, et al.
Digestive Diseases and Sciences|July 6, 2018
Screening Colonoscopy Withdrawal Time Threshold for Adequate Proximal Serrated Polyp Detection RateViral D Patel, William K Thompson, Brittany R Lapin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 11, 2005
Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placeboJay L Goldstein, Glenn M Eisen, Blair Lewis, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Journal of Clinical Gastroenterology|January 14, 2021
Bile Acid Sequestrant Therapy in Microscopic ColitisMichael J Northcutt, Nicole M Gentile, Jay L Goldstein, et al.
The American Journal of Gastroenterology|April 22, 2005
Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritisLinda Rabeneck, Jay L Goldstein, An Vu, et al.
The Journal of Rheumatology|January 5, 2005
Cyclooxygenase-2 specific inhibitors and upper gastrointestinal tolerability in patients with osteoarthritis receiving concomitant low dose aspirin: pooled analysis of 2 trialsJay L Goldstein, Alfonso E Bello, William Spalding, et al.
Digestive Diseases and Sciences|August 7, 2007
Endoscopic ulcer rates in healthy subjects associated with use of aspirin (81 mg q.d.) alone or coadministered with celecoxib or naproxen: a randomized, 1-week trialJay L Goldstein, James Aisenberg, Salam F Zakko, et al.
The American Journal of Gastroenterology|January 26, 2002
Reliability, validity, and responsiveness of severity of dyspepsia assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapyLinda Rabeneck, Kimberly Wristers, Jay L Goldstein, et al.
Digestive Diseases and Sciences|August 22, 2009
GERD-related health care utilization, therapy, and reasons for transfer of GERD patients between primary care providers and gastroenterologists in a US managed care settingRachel Halpern, Smita Kothari, Mahesh Fuldeore, et al.
Annals of the Rheumatic Diseases|August 5, 2006
The rate of NSAID-induced endoscopic ulcers increases linearly but not exponentially with age: a pooled analysis of 12 randomised trialsMaarten Boers, Marco J D Tangelder, Hein van Ingen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 8, 2006
Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complicationsJay L Goldstein, Kimberly B Howard, Surrey M Walton, et al.
Digestive Diseases and Sciences|July 6, 2018
Screening Colonoscopy Withdrawal Time Threshold for Adequate Proximal Serrated Polyp Detection RateViral D Patel, William K Thompson, Brittany R Lapin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 11, 2005
Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placeboJay L Goldstein, Glenn M Eisen, Blair Lewis, et al.
Pageof 7